US20180303488A1 - Stabilization of a transseptal delivery device - Google Patents
Stabilization of a transseptal delivery device Download PDFInfo
- Publication number
- US20180303488A1 US20180303488A1 US15/958,545 US201815958545A US2018303488A1 US 20180303488 A1 US20180303488 A1 US 20180303488A1 US 201815958545 A US201815958545 A US 201815958545A US 2018303488 A1 US2018303488 A1 US 2018303488A1
- Authority
- US
- United States
- Prior art keywords
- stabilizer
- anchor
- delivery device
- catheter
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M2025/0079—Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
Definitions
- the present disclosure relates to devices and methods for stabilizing a device positioned within a septal wall of a human heart. More particularly, it relates to devices and methods for transseptally accessing a left atrium of a heart for delivery of an apparatus, such as a prosthesis, ablation apparatus or other apparatus.
- the heart is a four-chambered pump that moves blood efficiently through the vascular system.
- Blood enters the heart through the vena cava and flows into the right atrium. From the right atrium, blood flows through the tricuspid valve and into the right ventricle, which then contracts and forces blood through the pulmonic valve and into the lungs.
- Oxygenated blood returns from the lungs and enters the heart through the left atrium and passes through the mitral valve into the left ventricle. The left ventricle contracts and pumps blood through the aortic valve into the aorta and to the vascular system.
- Heart valve replacement surgery is an open-heart procedure conducted under general anesthesia, during which the heart is stopped and blood flow is controlled by a heart-lung bypass machine.
- Traditional open-heart surgery inflicts significant patient trauma and discomfort, and exposes the patient to a number of potential risks, such as infection, stroke, renal failure, and adverse effects associated with the use of the heart-lung bypass machine, for example.
- a valve prosthesis is compacted for delivery in a catheter and then advanced, for example, through an opening in the femoral artery and through the patient's vasculature to the target site.
- a common approach for accessing the left side of the heart is a transseptal access from the right atrium through the intra-atrial septum and to the left atrium.
- Other heart treatment procedures can be conducted via transseptal delivery of a transcatheter device.
- Such procedures can include heart tissue ablation for treatment of concomitant disease or delivery of an appendage plug for occluding a left atrial appendage, for example.
- the disclosure addresses problems and limitations associated with related delivery devices for transseptally accessing a left atrium.
- the catheter includes a plurality of lumens.
- One lumen optionally can serve as a passageway for a prosthesis or other apparatus to be delivered to the left atrium. Additional lumens can serve as a delivery conduit for respective stabilizers or other devices.
- the stabilizers can be positioned within respective lumens. Once the delivery device is in position within the septal wall, an anchor of each stabilizer can be guided to and deployed to engage a pulmonary vein or a left atrial appendage to stabilize the delivery device, thus reducing the likelihood of damage to the septal wall as the catheter is navigated around the left atrium.
- the stabilizer includes one or more ablation elements. In other embodiments, the stabilizer can be disconnected from the delivery device for implantation, for example, within the left atrial appendage to occlude the atrial appendage.
- the method includes providing a delivery system including a delivery device having a catheter and at least one stabilizer. After the delivery device is advanced through the septal wall, the stabilizer is deployed from the catheter to stabilize the delivery device with respect to the septal wall. In various embodiments, each stabilizer is deployed to engage one respective pulmonary vein. In other embodiments, one stabilizer is deployed to engage the left atrial appendage. In some embodiments, once the stabilizer is deployed, the prosthesis or other apparatus can be delivered through one respective lumen in the delivery device to the left atrium for treatment of the heart.
- FIG. 1 is a cross-sectional illustration of a procedure for transseptally delivering an apparatus (not visible) to a left atrium of a human heart with a delivery device.
- FIG. 2 is a partial, schematic illustration of a delivery device including a catheter and two stabilizers.
- FIG. 3A is a partial, schematic illustration of a delivery device in a delivery position.
- FIG. 3B is a partial, schematic illustration of the delivery device of FIG. 3A in a deployed position.
- FIG. 4A is a partial, schematic illustration of an alternate delivery device in a delivery position.
- FIG. 4B is a partial, schematic illustration of the delivery device of FIG. 4A in a deployed position.
- FIG. 5A is a partial, schematic illustration of another delivery device in a delivery position.
- FIG. 5B is a partial, schematic illustration of the delivery device of FIG. 5A in a deployed position.
- FIG. 6 is a partial, schematic illustration of an alternate delivery device in an inflated, deployed position.
- FIG. 7 is a partial, schematic illustration of another delivery device in a deployed position, the delivery device including an anchor having at least one ablation element.
- distal and proximal are used in the following description with respect to a position or direction relative to the treating clinician. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician.
- FIG. 1 one example of a treatment procedure for a human heart 10 including an inferior vena cava 12 , right atrium 14 , septal wall 16 , left atrium 18 and a plurality of valves, including a mitral valve 20 , is generally depicted in FIG. 1 .
- a delivery device 30 including one or more coaxially arranged catheters 32 carrying an apparatus (not visible) is maneuvered over a guide wire 34 , typically routed through the vena cava 12 to the right atrium 14 and to the patient's septal wall 16 .
- the delivery path can continue transseptally through the patient's septal wall 16 to the left atrium 18 and resume, for example, by turning approximately 90° downward through the native mitral valve 20 or can travel to pulmonary veins 22 or a left atrial appendage 24 , depending on the procedure.
- One of the difficulties in either positioning the prosthesis or other apparatus in the left atrium 18 or crossing the mitral valve annulus 20 with a transcatheter delivery device is stabilizing the delivery device 30 within the septal wall 16 during movement of the catheter 32 .
- the point at which the catheter 32 passes through the septal wall 16 acts in some way as a stabilization point for the catheter 32 , the septal wall 16 hole can be further damaged during the articulation of the catheter tip 36 into and through the left atrium 18 .
- the embodiments of the present disclosure will allow for atraumatic stabilization of a delivery device positioned within a septal wall causing less trauma to the septal wall as treatment is conducted.
- the disclosed stabilized delivery devices also provide for a more rigid backstop against which the distal tip of the delivery device can be steered.
- the stabilizers disclosed herein can be configured to ablate pulmonary vein or left atrial appendage tissue.
- the stabilizers disclosed herein can also be configured to detach from the delivery device and occlude the left atrial appendage, as desired.
- FIG. 2 schematically illustrates a delivery device 50 having a catheter 52 (shown as truncated) including a plurality of lumens 54 .
- the catheter 52 is shown as having three lumens 54 , however, more or fewer lumens 54 can be provided.
- two lumens 54 are provided for respective stabilizers 60 .
- Each stabilizer 60 can include an actuating shaft 62 and an anchor 64 connected to a distal end 66 of the actuating shaft 62 .
- the anchor 64 is arranged and configured for engaging an inner surface of a respective pulmonary vein 22 .
- each anchor 64 has an outer diameter in the range of about 9 mm to about 35 mm.
- the anchors 64 are shown as being cylindrical but can take other shapes.
- the anchor 64 can be configured to allow blood to flow through the respective pulmonary vein 22 .
- the anchor 64 can be generally tubular.
- the stabilizer can be arranged and configured for engaging an inner surface of a left atrial appendage 24 . It may be desired to plug the left atrial appendage 24 after the delivery device is withdrawn from the patient and in this case, the anchor 64 can be configured to disengage from both the shaft 62 and delivery device 50 and the anchor 64 can further be configured to occlude the left atrial appendage 24 , as will be discussed in detail below.
- the stabilizers 60 of the delivery device 50 can be of the same configuration or can have different configurations.
- the disclosed stabilizers 60 can take a variety of configurations transitioning from a compressed, delivery arrangement to an expanded, deployed arrangement for engagement within a bodily lumen, such as one pulmonary vein 22 or atrial appendage 24 .
- a bodily lumen such as one pulmonary vein 22 or atrial appendage 24 .
- a few illustrative examples of how the stabilizers 60 can alternatively be configured are discussed below with respect to the remaining figures.
- a stabilizer 160 can include an actuator shaft 162 attached to an anchor 164 that can be a metal mesh cage made of nitinol or the like that has shape memory and is biased to a deployed position ( FIG. 3B ).
- the anchor 164 has a greatest outer diameter in the range of about 9 mm to about 35 mm and can come in a multitude of sizes.
- a sheath 168 is provided over the anchor 164 in the delivery arrangement ( FIG. 3A ) to compress and retain the anchor 164 against its natural bias.
- the sheath 168 can be proximally retracted to allow the anchor 164 to expand due to its natural bias.
- the anchor 164 is arranged and configured to expand and engage the anatomy, thus providing stability to the delivery device (see also FIGS. 1-2 ).
- the sheath 168 can be distally advanced over the anchor 164 to recapture and compress the anchor 164 within the sheath 168 for subsequent retraction and removal of the stabilizer 160 from the patient.
- the stabilizer 160 can be used with the delivery device 50 and the catheter 52 of FIG. 2 or an alternate delivery device.
- FIGS. 4A-4B shows a stabilizer 260 that can be used with the delivery device 50 and the catheter 52 of FIG. 2 or alternate delivery device.
- the stabilizer 260 includes an expandable anchor 264 interconnected to an actuating shaft 268 , which are both positioned over a rod 262 .
- the anchor 264 has a greatest outer diameter in the range of about 9 mm to about 35 mm and has any of the properties of the anchors 64 , 164 disclosed above.
- a distal end 266 a of the anchor 264 is fixedly secured to the rod 262 and a proximal end 266 b of the anchor 264 is fixedly secured to the actuating shaft 268 .
- proximal retraction of the actuating shaft 268 correspondingly pulls the proximal end 266 b of the anchor 264 proximally to correspondingly reduce the greatest outer diameter of the anchor 264 .
- This delivery position is illustrated in FIG. 4A .
- the actuating shaft 268 can be pushed distally to correspondingly push the proximal end 266 b of the anchor 264 closer to the distal end 266 a of the anchor 264 , thus expanding the greatest outer diameter of the anchor 264 to engage the anchor 264 with the vessel lumen and stabilize the delivery device.
- the shaft 268 can be fixed and to use proximal and distal movement of the rod 262 as an actuator in a similar manner.
- the rod 262 could be pushed distally with respect to the shaft 268 to collapse the anchor 264 and pulled proximally with respect to the shaft 268 to expand the anchor 264 (e.g., moving the distal end 266 a farther or closer to the proximal end 266 b ).
- the actuating shaft 268 can be proximally retracted to transition the anchor 264 back into the delivery position for withdrawal within the respective catheter lumen (see, e.g., catheter lumen 54 of FIG. 2 ).
- the stabilizer 360 includes a shaft 362 interconnected to an expandable anchor 364 .
- the anchor 364 has a greatest outer diameter in the range of about 9 mm to about 35 mm and has any of the properties of the anchors 64 , 164 , 264 disclosed above.
- a plurality of elongate tension members 368 extend along or through the shaft 362 and circumscribe the expandable anchor 364 . Each tension member 368 can be woven through the anchor 364 to maintain the tension member 368 in position around the anchor 364 .
- each tension member 368 extends proximally back through the shaft 362 .
- the tension members 368 are arranged and configured such that tension can be applied to the tension members 368 to compress and restrain the anchor 364 into the delivery position of FIG. 5A .
- the tension members 368 can be, for example, sutures, filaments, cables, cords or the like. In one example embodiment, three tension members 368 are provided.
- tension in the tension members 368 can be lessened, thus allowing a greatest outer diameter of the anchor 364 to expand, engage the vessel lumen and stabilize the delivery device.
- the tension members 368 can again be tensioned to compress the anchor 364 back into the delivery position for withdrawal within the respective catheter lumen (see also, FIG. 2 and related disclosure).
- the anchor 364 can optionally be housed within an outer, first balloon 370 and an inner, second balloon 372 .
- Each tension member 368 is at least partially retained between the two balloons 370 , 372 and functions in a similar manner as above in the embodiment where the balloons 370 , 372 are not provided.
- the second balloon 372 includes one or more channels 374 through which the tension members 368 is routed to and from the anchor 364 .
- the balloons 370 , 372 are made of a compliant material so that they can expand along with the anchor 364 . Suitable materials for balloons 370 , 372 include nylon, Pebax® thermoplastic elastomers, polyurethane, or the like and provide a particularly atraumatic stabilizer 360 .
- the stabilizer 460 includes a shaft 462 and an inflatable anchor 464 .
- the inflatable anchor 464 can, for example be a compliant balloon that is either elliptical or spherical upon inflation and made of nylon, Pebax® thermoplastic elastomers, polyurethane, or the like.
- the anchor 464 has a greatest outer diameter in the range of about 9 mm to about 35 mm.
- the anchor 464 can be inflated via an inflation channel 470 in the shaft 462 or otherwise until the anchor 464 engages a vessel lumen, such as a pulmonary vein or atrial appendage, to stabilize the delivery device. Once the treatment procedure is complete, the anchor 464 can be deflated to transition the anchor 464 back into the delivery position for withdrawal within the respective catheter lumen (see also, FIG. 2 and related disclosure).
- a stabilizer 560 can include one or more ablation elements 572 positioned on an anchor 564 can be electrically connected to an ablation source via a wire 574 and configured to transfer ablation energy from the ablation source (not shown) to tissue (e.g., to the pulmonary vein 22 or atrial appendage 24 shown in FIG. 1 ). If multiple ablation elements 572 are positioned on each stabilizer 560 , they may be configured to be individually energized so that deployment position of the stabilizer 560 does not have to be very precise.
- the stabilizer 560 can otherwise take any of the forms and can be actuated similarly to any other of the stabilizers disclosed herein.
- the anchor 564 can be positioned over a rod 562 and expansion and contraction of the anchor 564 can be controlled with a shaft 568 as also discussed above with respect to FIGS. 4A-4B .
- the ablation elements e.g., ablation elements 572
- the ablation elements are placed at the ostium of the pulmonary veins or the ostium of the left atrial appendage.
- a multitude of electrodes e.g., ablation elements 572
- RF radio frequency
- All of the above embodiments can optionally be configured to release the anchor from the stabilizer and delivery device. Release from the delivery device could be done mechanically.
- a ball in socket mechanism could be used to attach the stabilizer to the actuating shaft (e.g., 62 ) and released by use of an actuator in a user handle of the delivery device (not shown) or the socket itself could be retractable into the catheter and made of a memory shape material such as Nitinol where retraction would cause the socket to change shape and release from the stabilizer.
- release of the anchor could be accomplished by looping a suture or the like through the anchor material (e.g. metal mesh cage) and threaded back through the catheter.
- the suture could be cut and removed at a proximal end of the catheter, exterior to the patient, by the clinician to selectively release the anchor.
- the delivery device could provide an electromagnetic connection between the anchor and the shaft that could be modulated via current injected into the shaft to selectively release the anchor.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Surgical Instruments (AREA)
Abstract
A transcatheter delivery device including a catheter and at least one stabilizer useful for trasnsseptal procedures. The stabilizer includes a shaft connected to an anchor. The anchor has a delivery position in which the anchor is collapsed against the shaft and a deployed position in which the anchor expands to engage a pulmonary vein or atrial appendage to support the catheter within the septal wall as the catheter moves within a left atrium. Various disclosed delivery devices are also configured to ablate tissue proximate the anchor and/or can be disconnected from the delivery device after the procedure to occlude an atrial appendage. Methods of using the disclosed delivery devices and treating a heart are also disclosed.
Description
- This Non-Provisional Patent Application claims the benefit of the filing date of U.S. Provisional Patent Application Ser. No. 62/487,836, filed Apr. 20, 2017, the entire teachings of which are incorporated herein by reference.
- The present disclosure relates to devices and methods for stabilizing a device positioned within a septal wall of a human heart. More particularly, it relates to devices and methods for transseptally accessing a left atrium of a heart for delivery of an apparatus, such as a prosthesis, ablation apparatus or other apparatus.
- The heart is a four-chambered pump that moves blood efficiently through the vascular system. Blood enters the heart through the vena cava and flows into the right atrium. From the right atrium, blood flows through the tricuspid valve and into the right ventricle, which then contracts and forces blood through the pulmonic valve and into the lungs. Oxygenated blood returns from the lungs and enters the heart through the left atrium and passes through the mitral valve into the left ventricle. The left ventricle contracts and pumps blood through the aortic valve into the aorta and to the vascular system.
- Diseased or otherwise deficient heart valves can be repaired or replaced with an implanted prosthetic heart valve. Conventionally, heart valve replacement surgery is an open-heart procedure conducted under general anesthesia, during which the heart is stopped and blood flow is controlled by a heart-lung bypass machine. Traditional open-heart surgery inflicts significant patient trauma and discomfort, and exposes the patient to a number of potential risks, such as infection, stroke, renal failure, and adverse effects associated with the use of the heart-lung bypass machine, for example.
- Due to the drawbacks of open-heart surgical procedures, there has been an increased interest in minimally invasive and percutaneous replacement of cardiac valves. With these percutaneous transcatheter (or transluminal) techniques, a valve prosthesis is compacted for delivery in a catheter and then advanced, for example, through an opening in the femoral artery and through the patient's vasculature to the target site. A common approach for accessing the left side of the heart is a transseptal access from the right atrium through the intra-atrial septum and to the left atrium.
- Other heart treatment procedures can be conducted via transseptal delivery of a transcatheter device. Such procedures can include heart tissue ablation for treatment of concomitant disease or delivery of an appendage plug for occluding a left atrial appendage, for example.
- The disclosure addresses problems and limitations associated with related delivery devices for transseptally accessing a left atrium.
- One aspect of the present disclosure relates to a delivery device including a catheter and at least one stabilizer. In various embodiments, the catheter includes a plurality of lumens. One lumen optionally can serve as a passageway for a prosthesis or other apparatus to be delivered to the left atrium. Additional lumens can serve as a delivery conduit for respective stabilizers or other devices. During advancement of the delivery device through a septal wall, the stabilizers can be positioned within respective lumens. Once the delivery device is in position within the septal wall, an anchor of each stabilizer can be guided to and deployed to engage a pulmonary vein or a left atrial appendage to stabilize the delivery device, thus reducing the likelihood of damage to the septal wall as the catheter is navigated around the left atrium. In various embodiments, the stabilizer includes one or more ablation elements. In other embodiments, the stabilizer can be disconnected from the delivery device for implantation, for example, within the left atrial appendage to occlude the atrial appendage.
- Another aspect of the present disclosure relates to methods of delivering an apparatus, such as a prosthesis, ablation or other apparatus, to the left atrium via transseptal delivery. The method includes providing a delivery system including a delivery device having a catheter and at least one stabilizer. After the delivery device is advanced through the septal wall, the stabilizer is deployed from the catheter to stabilize the delivery device with respect to the septal wall. In various embodiments, each stabilizer is deployed to engage one respective pulmonary vein. In other embodiments, one stabilizer is deployed to engage the left atrial appendage. In some embodiments, once the stabilizer is deployed, the prosthesis or other apparatus can be delivered through one respective lumen in the delivery device to the left atrium for treatment of the heart. In other embodiments, ablation is performed with the stabilizer, once deployed. Once a treatment procedure within the left atrium is complete, the stabilizer can optionally be disengaged from the respective anatomy, transitioned to the delivery position and then withdrawn from the patient along with the delivery device. Alternatively, the stabilizer can be disconnected from the delivery device and left within the patient (e.g., to occlude the left atrial appendage).
-
FIG. 1 is a cross-sectional illustration of a procedure for transseptally delivering an apparatus (not visible) to a left atrium of a human heart with a delivery device. -
FIG. 2 is a partial, schematic illustration of a delivery device including a catheter and two stabilizers. -
FIG. 3A is a partial, schematic illustration of a delivery device in a delivery position. -
FIG. 3B is a partial, schematic illustration of the delivery device ofFIG. 3A in a deployed position. -
FIG. 4A is a partial, schematic illustration of an alternate delivery device in a delivery position. -
FIG. 4B is a partial, schematic illustration of the delivery device ofFIG. 4A in a deployed position. -
FIG. 5A is a partial, schematic illustration of another delivery device in a delivery position. -
FIG. 5B is a partial, schematic illustration of the delivery device ofFIG. 5A in a deployed position. -
FIG. 6 is a partial, schematic illustration of an alternate delivery device in an inflated, deployed position. -
FIG. 7 is a partial, schematic illustration of another delivery device in a deployed position, the delivery device including an anchor having at least one ablation element. - Specific embodiments of the present disclosure are now described with reference to the figures, wherein like reference numbers indicate identical or functionally similar elements. The terms “distal” and “proximal” are used in the following description with respect to a position or direction relative to the treating clinician. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician.
- By way of background, one example of a treatment procedure for a
human heart 10 including aninferior vena cava 12,right atrium 14,septal wall 16,left atrium 18 and a plurality of valves, including amitral valve 20, is generally depicted inFIG. 1 . In this example, adelivery device 30 including one or more coaxially arrangedcatheters 32 carrying an apparatus (not visible) is maneuvered over aguide wire 34, typically routed through thevena cava 12 to theright atrium 14 and to the patient'sseptal wall 16. The delivery path can continue transseptally through the patient'sseptal wall 16 to theleft atrium 18 and resume, for example, by turning approximately 90° downward through the nativemitral valve 20 or can travel topulmonary veins 22 or a leftatrial appendage 24, depending on the procedure. One of the difficulties in either positioning the prosthesis or other apparatus in theleft atrium 18 or crossing themitral valve annulus 20 with a transcatheter delivery device is stabilizing thedelivery device 30 within theseptal wall 16 during movement of thecatheter 32. Although the point at which thecatheter 32 passes through theseptal wall 16 acts in some way as a stabilization point for thecatheter 32, theseptal wall 16 hole can be further damaged during the articulation of thecatheter tip 36 into and through theleft atrium 18. It is believed that the embodiments of the present disclosure will allow for atraumatic stabilization of a delivery device positioned within a septal wall causing less trauma to the septal wall as treatment is conducted. In addition, the disclosed stabilized delivery devices also provide for a more rigid backstop against which the distal tip of the delivery device can be steered. In further embodiments, the stabilizers disclosed herein can be configured to ablate pulmonary vein or left atrial appendage tissue. In addition, the stabilizers disclosed herein can also be configured to detach from the delivery device and occlude the left atrial appendage, as desired. - Turning now also to
FIG. 2 , which schematically illustrates adelivery device 50 having a catheter 52 (shown as truncated) including a plurality oflumens 54. Thecatheter 52 is shown as having threelumens 54, however, more orfewer lumens 54 can be provided. In this embodiment, twolumens 54 are provided forrespective stabilizers 60. Eachstabilizer 60 can include anactuating shaft 62 and ananchor 64 connected to a distal end 66 of the actuatingshaft 62. In some embodiments, theanchor 64 is arranged and configured for engaging an inner surface of a respectivepulmonary vein 22. In one example embodiment, eachanchor 64 has an outer diameter in the range of about 9 mm to about 35 mm. Theanchors 64 are shown as being cylindrical but can take other shapes. In addition, theanchor 64 can be configured to allow blood to flow through the respectivepulmonary vein 22. For example, theanchor 64 can be generally tubular. Alternatively, the stabilizer can be arranged and configured for engaging an inner surface of a leftatrial appendage 24. It may be desired to plug the leftatrial appendage 24 after the delivery device is withdrawn from the patient and in this case, theanchor 64 can be configured to disengage from both theshaft 62 anddelivery device 50 and theanchor 64 can further be configured to occlude the leftatrial appendage 24, as will be discussed in detail below. Thestabilizers 60 of thedelivery device 50 can be of the same configuration or can have different configurations. - The disclosed
stabilizers 60 can take a variety of configurations transitioning from a compressed, delivery arrangement to an expanded, deployed arrangement for engagement within a bodily lumen, such as onepulmonary vein 22 oratrial appendage 24. A few illustrative examples of how thestabilizers 60 can alternatively be configured are discussed below with respect to the remaining figures. - In one embodiment schematically illustrated in
FIGS. 3A-3B , astabilizer 160 can include anactuator shaft 162 attached to ananchor 164 that can be a metal mesh cage made of nitinol or the like that has shape memory and is biased to a deployed position (FIG. 3B ). In one example embodiment, theanchor 164 has a greatest outer diameter in the range of about 9 mm to about 35 mm and can come in a multitude of sizes. Asheath 168 is provided over theanchor 164 in the delivery arrangement (FIG. 3A ) to compress and retain theanchor 164 against its natural bias. Once theanchor 164 is positioned within the respective lumen of the anatomy, thesheath 168 can be proximally retracted to allow theanchor 164 to expand due to its natural bias. Theanchor 164 is arranged and configured to expand and engage the anatomy, thus providing stability to the delivery device (see alsoFIGS. 1-2 ). Once the procedure is complete and the delivery device is to be withdrawn, thesheath 168 can be distally advanced over theanchor 164 to recapture and compress theanchor 164 within thesheath 168 for subsequent retraction and removal of thestabilizer 160 from the patient. Thestabilizer 160 can be used with thedelivery device 50 and thecatheter 52 ofFIG. 2 or an alternate delivery device. - Yet another embodiment is illustrated in
FIGS. 4A-4B , which shows astabilizer 260 that can be used with thedelivery device 50 and thecatheter 52 ofFIG. 2 or alternate delivery device. Thestabilizer 260 includes anexpandable anchor 264 interconnected to anactuating shaft 268, which are both positioned over arod 262. In one example embodiment, theanchor 264 has a greatest outer diameter in the range of about 9 mm to about 35 mm and has any of the properties of theanchors distal end 266 a of theanchor 264 is fixedly secured to therod 262 and aproximal end 266 b of theanchor 264 is fixedly secured to theactuating shaft 268. In this embodiment, proximal retraction of theactuating shaft 268 correspondingly pulls theproximal end 266 b of theanchor 264 proximally to correspondingly reduce the greatest outer diameter of theanchor 264. This delivery position is illustrated inFIG. 4A . To transition theanchor 264 into the deployed position ofFIG. 4B , theactuating shaft 268 can be pushed distally to correspondingly push theproximal end 266 b of theanchor 264 closer to thedistal end 266 a of theanchor 264, thus expanding the greatest outer diameter of theanchor 264 to engage theanchor 264 with the vessel lumen and stabilize the delivery device. Another option would be to configure theshaft 268 to be fixed and to use proximal and distal movement of therod 262 as an actuator in a similar manner. For example, therod 262 could be pushed distally with respect to theshaft 268 to collapse theanchor 264 and pulled proximally with respect to theshaft 268 to expand the anchor 264 (e.g., moving thedistal end 266 a farther or closer to theproximal end 266 b). Once the treatment procedure is complete, theactuating shaft 268 can be proximally retracted to transition theanchor 264 back into the delivery position for withdrawal within the respective catheter lumen (see, e.g.,catheter lumen 54 ofFIG. 2 ). - Referring also now to
FIGS. 5A-5B , which illustrate analternate stabilizer 360 that can be used with thedelivery device 50 and thecatheter 52 ofFIG. 2 or other delivery device. Thestabilizer 360 includes ashaft 362 interconnected to anexpandable anchor 364. In one example embodiment, theanchor 364 has a greatest outer diameter in the range of about 9 mm to about 35 mm and has any of the properties of theanchors elongate tension members 368 extend along or through theshaft 362 and circumscribe theexpandable anchor 364. Eachtension member 368 can be woven through theanchor 364 to maintain thetension member 368 in position around theanchor 364. After wrapping around theanchor 364, eachtension member 368 extends proximally back through theshaft 362. Thetension members 368 are arranged and configured such that tension can be applied to thetension members 368 to compress and restrain theanchor 364 into the delivery position ofFIG. 5A . Thetension members 368 can be, for example, sutures, filaments, cables, cords or the like. In one example embodiment, threetension members 368 are provided. To deploy theanchor 364 into the deployed position ofFIG. 5B , tension in thetension members 368 can be lessened, thus allowing a greatest outer diameter of theanchor 364 to expand, engage the vessel lumen and stabilize the delivery device. Once the treatment procedure is complete, thetension members 368 can again be tensioned to compress theanchor 364 back into the delivery position for withdrawal within the respective catheter lumen (see also,FIG. 2 and related disclosure). - As shown, the
anchor 364 can optionally be housed within an outer,first balloon 370 and an inner,second balloon 372. Eachtension member 368 is at least partially retained between the twoballoons balloons second balloon 372 includes one ormore channels 374 through which thetension members 368 is routed to and from theanchor 364. Theballoons anchor 364. Suitable materials forballoons atraumatic stabilizer 360. - Referring now also to
FIG. 6 , which illustrates analternate stabilizer 460 that can be used with thedelivery device 50 and thecatheter 52 ofFIG. 2 . Thestabilizer 460 includes ashaft 462 and aninflatable anchor 464. Theinflatable anchor 464 can, for example be a compliant balloon that is either elliptical or spherical upon inflation and made of nylon, Pebax® thermoplastic elastomers, polyurethane, or the like. In one example embodiment, theanchor 464 has a greatest outer diameter in the range of about 9 mm to about 35 mm. To deploy theanchor 464 from a delivery position in which theanchor 464 is deflated (not shown) into the deployed position ofFIG. 6 in which a greatest diameter of theanchor 464 is increased as compared to the delivery position, theanchor 464 can be inflated via aninflation channel 470 in theshaft 462 or otherwise until theanchor 464 engages a vessel lumen, such as a pulmonary vein or atrial appendage, to stabilize the delivery device. Once the treatment procedure is complete, theanchor 464 can be deflated to transition theanchor 464 back into the delivery position for withdrawal within the respective catheter lumen (see also,FIG. 2 and related disclosure). - As schematically illustrated in
FIG. 7 , all of the stabilizers disclosed herein can also optionally be configured to ablate tissue of the anatomy proximate which the stabilizer is engaged. In one example embodiment, astabilizer 560 can include one ormore ablation elements 572 positioned on ananchor 564 can be electrically connected to an ablation source via awire 574 and configured to transfer ablation energy from the ablation source (not shown) to tissue (e.g., to thepulmonary vein 22 oratrial appendage 24 shown inFIG. 1 ). Ifmultiple ablation elements 572 are positioned on eachstabilizer 560, they may be configured to be individually energized so that deployment position of thestabilizer 560 does not have to be very precise. Fewer ormore ablation elements 572 can be utilized, as desired. Thestabilizer 560 can otherwise take any of the forms and can be actuated similarly to any other of the stabilizers disclosed herein. As one illustrated example, theanchor 564 can be positioned over arod 562 and expansion and contraction of theanchor 564 can be controlled with ashaft 568 as also discussed above with respect toFIGS. 4A-4B . - In one example, the ablation elements (e.g., ablation elements 572) are placed at the ostium of the pulmonary veins or the ostium of the left atrial appendage. In yet another example, a multitude of electrodes (e.g., ablation elements 572) are provided on the anchor that are capable of delivering radio frequency (RF) energy or high voltage pulses to deliver irreversible electroporation.
- All of the above embodiments can optionally be configured to release the anchor from the stabilizer and delivery device. Release from the delivery device could be done mechanically. For example, a ball in socket mechanism could be used to attach the stabilizer to the actuating shaft (e.g., 62) and released by use of an actuator in a user handle of the delivery device (not shown) or the socket itself could be retractable into the catheter and made of a memory shape material such as Nitinol where retraction would cause the socket to change shape and release from the stabilizer. Alternatively, release of the anchor could be accomplished by looping a suture or the like through the anchor material (e.g. metal mesh cage) and threaded back through the catheter. The suture could be cut and removed at a proximal end of the catheter, exterior to the patient, by the clinician to selectively release the anchor. In yet another embodiment, the delivery device could provide an electromagnetic connection between the anchor and the shaft that could be modulated via current injected into the shaft to selectively release the anchor.
- Although the present disclosure has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and scope of the present disclosure.
Claims (20)
1. A delivery device for transseptal delivery of an apparatus to a human heart from a right atrium, through a septal wall and into a left atrium of the human heart; the delivery device comprising:
a catheter including a first lumen in which a stabilizer is positioned; wherein the stabilizer has a delivery position in which the stabilizer is contained within the first lumen and a deployed position in which the stabilizer interconnects a portion of the human heart and the catheter; wherein the stabilizer is configured to engage a portion of a human heart selected from the group consisting of a pulmonary vein and a left atrium appendage.
2. The delivery device of claim 1 , wherein catheter includes a second lumen in which a second stabilizer is positioned.
3. The delivery device of claim 1 , wherein the stabilizer can be detached from the delivery device.
4. The delivery device of claim 1 , wherein the stabilizer is configured to be non-occluding.
5. The delivery device of claim 1 , wherein the stabilizer is a metal cage.
6. The delivery device of claim 1 , wherein the stabilizer includes an ablation element.
7. The delivery device of claim 6 , wherein the stabilizer includes a plurality of ablation elements spaced longitudinally along the stabilizer.
8. The delivery device of claim 1 , wherein the stabilizer is inflatable.
9. The delivery device of claim 1 , wherein the stabilizer includes an anchor secured to an actuator shaft that can vary a diameter of the anchor.
10. The delivery device of claim 1 , wherein the delivery device includes a plurality of tension members that can vary a diameter of the stabilizer.
11. A method of stabilizing a catheter during transseptal access of a left atrium of a heart of a patient; the method comprising the steps of:
providing a first delivery device including:
a catheter and a first stabilizer positioned within the catheter; the stabilizer including a first anchor secured to a first shaft, the first anchor having a delivery position and a deployed position; wherein a diameter of the first stabilizer is greater in the deployed position than in the delivery position;
with the first stabilizer in the delivery position, directing the delivery device through a vascular system of the patient to position the delivery device within a septal wall; and
deploying the first stabilizer so that the first anchor engages one of a first pulmonary vein and a left atrial appendage.
12. The method of claim 11 , wherein catheter includes a second lumen in which a second stabilizer is positioned and the method further includes the step of deploying a second anchor of the second stabilizer to engage one of a second pulmonary vein and the left atrial appendage.
13. The method of claim 11 , wherein the method further includes the step of detaching the first anchor from the first shaft.
14. The method of claim 11 , wherein the first stabilizer is configured to be non-occluding.
15. The method of claim 11 , wherein the first stabilizer is a metal cage.
16. The method of claim 11 , wherein the first anchor includes an ablation element, the method further comprising the step of ablating tissue adjacent the first anchor.
17. The method of claim 16 , wherein the first anchor includes a plurality of ablation elements spaced longitudinally along the first anchor.
18. The method of claim 11 , wherein the first anchor is inflated to engage one of the first pulmonary vein and the left atrial appendage.
19. The method of claim 11 , wherein the first anchor is secured to an actuator shaft; the method further comprising the step of adjusting the position of the actuator shaft to vary a diameter of the first anchor.
20. The method of claim 11 , wherein the delivery device includes a plurality of tension members that can vary a diameter of the first anchor.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/958,545 US20180303488A1 (en) | 2017-04-20 | 2018-04-20 | Stabilization of a transseptal delivery device |
US17/102,694 US11832829B2 (en) | 2017-04-20 | 2020-11-24 | Stabilization of a transseptal delivery device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762487836P | 2017-04-20 | 2017-04-20 | |
US15/958,545 US20180303488A1 (en) | 2017-04-20 | 2018-04-20 | Stabilization of a transseptal delivery device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/102,694 Division US11832829B2 (en) | 2017-04-20 | 2020-11-24 | Stabilization of a transseptal delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180303488A1 true US20180303488A1 (en) | 2018-10-25 |
Family
ID=62117059
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/958,545 Abandoned US20180303488A1 (en) | 2017-04-20 | 2018-04-20 | Stabilization of a transseptal delivery device |
US17/102,694 Active 2039-01-09 US11832829B2 (en) | 2017-04-20 | 2020-11-24 | Stabilization of a transseptal delivery device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/102,694 Active 2039-01-09 US11832829B2 (en) | 2017-04-20 | 2020-11-24 | Stabilization of a transseptal delivery device |
Country Status (3)
Country | Link |
---|---|
US (2) | US20180303488A1 (en) |
EP (2) | EP4005500A1 (en) |
WO (1) | WO2018195432A1 (en) |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10433908B2 (en) | 2016-01-05 | 2019-10-08 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US10595994B1 (en) | 2018-09-20 | 2020-03-24 | Vdyne, Llc | Side-delivered transcatheter heart valve replacement |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US10631983B1 (en) | 2019-03-14 | 2020-04-28 | Vdyne, Inc. | Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis |
US10653522B1 (en) | 2018-12-20 | 2020-05-19 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valve prosthesis |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US20200269059A1 (en) * | 2019-02-20 | 2020-08-27 | Ablation Innovations, LLC | Apparatus, systems, and methods to improve atrial fibrillation outcomes involving the left atrial appendage |
US10758346B1 (en) | 2019-03-14 | 2020-09-01 | Vdyne, Inc. | A2 clip for side-delivered transcatheter mitral valve prosthesis |
US10799241B2 (en) | 2009-04-01 | 2020-10-13 | Sentreheart Llc | Tissue ligation devices and controls therefor |
US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
EP3772339A1 (en) * | 2019-08-05 | 2021-02-10 | Biotronik Ag | Medical closure device for closing the left atrial appendage |
US10966725B2 (en) | 2007-03-30 | 2021-04-06 | Sentreheart Llc | Devices and systems for closing the left atrial appendage |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
US11109969B2 (en) | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
US11166814B2 (en) | 2019-08-20 | 2021-11-09 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
US11202706B2 (en) | 2019-05-04 | 2021-12-21 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
US11224435B2 (en) | 2016-09-23 | 2022-01-18 | Sentreheart Llc | Devices and Methods for left atrial appendage closure |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
US11241282B2 (en) | 2014-06-12 | 2022-02-08 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
WO2022047333A1 (en) * | 2020-08-31 | 2022-03-03 | Laminar, Inc. | Devices, systems, and methods for treating a tissue of the heart |
US11273033B2 (en) | 2018-09-20 | 2022-03-15 | Vdyne, Inc. | Side-delivered transcatheter heart valve replacement |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US20220096087A1 (en) * | 2019-06-12 | 2022-03-31 | Edwards Lifesciences Corporation | Fluid bypass conduit for left atrial pressure management |
US11298227B2 (en) | 2019-03-05 | 2022-04-12 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
US11331186B2 (en) | 2019-08-26 | 2022-05-17 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11786366B2 (en) | 2018-04-04 | 2023-10-17 | Vdyne, Inc. | Devices and methods for anchoring transcatheter heart valve |
US11832829B2 (en) | 2017-04-20 | 2023-12-05 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
US11844526B2 (en) | 2018-03-27 | 2023-12-19 | Atricure, Inc. | Devices and methods for left atrial appendage closure |
CN117338365A (en) * | 2023-12-06 | 2024-01-05 | 东南大学泰州生物医药与医疗器械研究院 | Left auricle plugging device |
US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5740808A (en) * | 1996-10-28 | 1998-04-21 | Ep Technologies, Inc | Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions |
US20090018538A1 (en) * | 2007-07-12 | 2009-01-15 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US20150018940A1 (en) * | 2013-07-10 | 2015-01-15 | Medtronic, Inc. | Helical coil mitral valve annuloplasty systems and methods |
US20160242788A1 (en) * | 2015-02-23 | 2016-08-25 | Atricure, Inc. | Medical devices |
US20160374754A1 (en) * | 2013-05-20 | 2016-12-29 | Mayo Foundation For Medical Education And Research | Devices and methods for ablation of tissue |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6311692B1 (en) * | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6152144A (en) * | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
CA2369312C (en) * | 1999-05-11 | 2009-11-24 | Atrionix, Inc. | Balloon anchor wire |
CA2446920A1 (en) * | 2001-05-21 | 2002-11-28 | Medtronic, Inc. | Trans-septal catheter with retention mechanism |
US20040215310A1 (en) * | 2002-01-17 | 2004-10-28 | Omar Amirana | Stent and delivery method for applying RF energy to a pulmonary vein and the atrial wall around its ostium to eliminate atrial fibrillation while preventing stenosis of the pulmonary vein thereafter |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US20040260394A1 (en) | 2003-06-20 | 2004-12-23 | Medtronic Vascular, Inc. | Cardiac valve annulus compressor system |
ATE442107T1 (en) | 2003-07-21 | 2009-09-15 | Univ Pennsylvania | PERCUTANE HEART VALVE |
US20060069385A1 (en) | 2004-09-28 | 2006-03-30 | Scimed Life Systems, Inc. | Methods and apparatus for tissue cryotherapy |
US7402151B2 (en) | 2004-12-17 | 2008-07-22 | Biocardia, Inc. | Steerable guide catheters and methods for their use |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US8105375B2 (en) | 2007-01-19 | 2012-01-31 | The Cleveland Clinic Foundation | Method for implanting a cardiovascular valve |
US8900214B2 (en) * | 2007-03-30 | 2014-12-02 | Onset Medical Corporation | Expandable trans-septal sheath |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US20100217382A1 (en) * | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
US10433956B2 (en) | 2010-02-24 | 2019-10-08 | Medtronic Ventor Technologies Ltd. | Mitral prosthesis and methods for implantation |
US8512401B2 (en) | 2010-04-12 | 2013-08-20 | Medtronic, Inc. | Transcatheter prosthetic heart valve delivery system with funnel recapturing feature and method |
CN104997574B (en) * | 2010-04-13 | 2017-06-06 | 森特里心脏股份有限公司 | For the method and apparatus to Cardiac interventional and placing device |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
DE202010011492U1 (en) | 2010-08-17 | 2010-10-28 | Osypka, Peter, Dr.-Ing. | Cardiac catheter with fixation in the septum |
AU2011295854B2 (en) | 2010-09-01 | 2016-07-21 | Mvalve Technologies Ltd. | Cardiac valve support structure |
EP2723273B1 (en) | 2011-06-21 | 2021-10-27 | Twelve, Inc. | Prosthetic heart valve devices |
US9364637B2 (en) | 2011-09-06 | 2016-06-14 | Medtronic, Inc. | Transcatheter balloon-assisted mitral valve navigation device and method |
EP2785282A4 (en) | 2011-12-01 | 2016-01-13 | Univ Pennsylvania | Percutaneous valve replacement devices |
US10226339B2 (en) | 2012-01-31 | 2019-03-12 | Mitral Valve Technologies Sarl | Mitral valve docking devices, systems and methods |
US9180008B2 (en) | 2012-02-29 | 2015-11-10 | Valcare, Inc. | Methods, devices, and systems for percutaneously anchoring annuloplasty rings |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
WO2015073970A1 (en) * | 2013-11-15 | 2015-05-21 | The Johns Hopkins University | Transseptal access stability system |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
WO2015127283A1 (en) | 2014-02-21 | 2015-08-27 | Cardiaq Valve Technologies, Inc. | Delivery device for controlled deployement of a replacement valve |
US20150238729A1 (en) * | 2014-02-24 | 2015-08-27 | Mark Lynn Jenson | Cardiac Access Catheter, System, and Method |
WO2015160598A1 (en) | 2014-04-17 | 2015-10-22 | Medtronic Vascular Galway | Hinged transcatheter prosthetic heart valve delivery system |
EP3169260B1 (en) | 2014-07-16 | 2019-09-25 | Fractyl Laboratories, Inc. | System for treating diabetes and related diseases and disorders |
US9743972B2 (en) * | 2014-07-18 | 2017-08-29 | Medtronic Cryocath Lp | Cardiac cryolipolysis for the treatment of cardiac arrhythmia |
US20210137681A1 (en) | 2017-03-20 | 2021-05-13 | Medtronic Vascular, Inc. | Delivery Systems and Methods fro Transseptal Access to a Left Atrium |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
WO2018195432A1 (en) | 2017-04-20 | 2018-10-25 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
WO2019023328A1 (en) * | 2017-07-26 | 2019-01-31 | Innoblative Designs, Inc. | Minimally invasive articulating assembly having ablation capabilities |
-
2018
- 2018-04-20 WO PCT/US2018/028583 patent/WO2018195432A1/en unknown
- 2018-04-20 EP EP21214634.4A patent/EP4005500A1/en active Pending
- 2018-04-20 US US15/958,545 patent/US20180303488A1/en not_active Abandoned
- 2018-04-20 EP EP18723213.7A patent/EP3612103B1/en active Active
-
2020
- 2020-11-24 US US17/102,694 patent/US11832829B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5740808A (en) * | 1996-10-28 | 1998-04-21 | Ep Technologies, Inc | Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions |
US20090018538A1 (en) * | 2007-07-12 | 2009-01-15 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US20160374754A1 (en) * | 2013-05-20 | 2016-12-29 | Mayo Foundation For Medical Education And Research | Devices and methods for ablation of tissue |
US20150018940A1 (en) * | 2013-07-10 | 2015-01-15 | Medtronic, Inc. | Helical coil mitral valve annuloplasty systems and methods |
US20160242788A1 (en) * | 2015-02-23 | 2016-08-25 | Atricure, Inc. | Medical devices |
Cited By (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11020122B2 (en) | 2007-03-30 | 2021-06-01 | Sentreheart Llc | Methods for closing the left atrial appendage |
US10966725B2 (en) | 2007-03-30 | 2021-04-06 | Sentreheart Llc | Devices and systems for closing the left atrial appendage |
US11826050B2 (en) | 2007-03-30 | 2023-11-28 | Atricure, Inc. | Devices, systems, and methods for closing the left atrial appendage |
US11950784B2 (en) | 2009-04-01 | 2024-04-09 | Atricure, Inc. | Tissue ligation devices and controls therefor |
US10799241B2 (en) | 2009-04-01 | 2020-10-13 | Sentreheart Llc | Tissue ligation devices and controls therefor |
US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
US11622803B2 (en) | 2014-06-12 | 2023-04-11 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US11241282B2 (en) | 2014-06-12 | 2022-02-08 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
US10433908B2 (en) | 2016-01-05 | 2019-10-08 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10512779B2 (en) | 2016-01-05 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11589921B2 (en) | 2016-01-05 | 2023-02-28 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11020179B2 (en) | 2016-01-05 | 2021-06-01 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
US11224435B2 (en) | 2016-09-23 | 2022-01-18 | Sentreheart Llc | Devices and Methods for left atrial appendage closure |
US11832829B2 (en) | 2017-04-20 | 2023-12-05 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
US11833350B2 (en) | 2017-04-28 | 2023-12-05 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
US11844526B2 (en) | 2018-03-27 | 2023-12-19 | Atricure, Inc. | Devices and methods for left atrial appendage closure |
US11786366B2 (en) | 2018-04-04 | 2023-10-17 | Vdyne, Inc. | Devices and methods for anchoring transcatheter heart valve |
US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US11273033B2 (en) | 2018-09-20 | 2022-03-15 | Vdyne, Inc. | Side-delivered transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US10595994B1 (en) | 2018-09-20 | 2020-03-24 | Vdyne, Llc | Side-delivered transcatheter heart valve replacement |
US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
US11109969B2 (en) | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US10653522B1 (en) | 2018-12-20 | 2020-05-19 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valve prosthesis |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
US20200269059A1 (en) * | 2019-02-20 | 2020-08-27 | Ablation Innovations, LLC | Apparatus, systems, and methods to improve atrial fibrillation outcomes involving the left atrial appendage |
US11298227B2 (en) | 2019-03-05 | 2022-04-12 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US10631983B1 (en) | 2019-03-14 | 2020-04-28 | Vdyne, Inc. | Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis |
US10758346B1 (en) | 2019-03-14 | 2020-09-01 | Vdyne, Inc. | A2 clip for side-delivered transcatheter mitral valve prosthesis |
US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
US11202706B2 (en) | 2019-05-04 | 2021-12-21 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
US20220096087A1 (en) * | 2019-06-12 | 2022-03-31 | Edwards Lifesciences Corporation | Fluid bypass conduit for left atrial pressure management |
EP3772339A1 (en) * | 2019-08-05 | 2021-02-10 | Biotronik Ag | Medical closure device for closing the left atrial appendage |
US11179239B2 (en) | 2019-08-20 | 2021-11-23 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
US11166814B2 (en) | 2019-08-20 | 2021-11-09 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
US11331186B2 (en) | 2019-08-26 | 2022-05-17 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11738200B2 (en) | 2019-09-17 | 2023-08-29 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US10688305B1 (en) | 2019-09-17 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11931090B2 (en) | 2019-11-20 | 2024-03-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11684408B2 (en) | 2019-11-20 | 2023-06-27 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
WO2022047333A1 (en) * | 2020-08-31 | 2022-03-03 | Laminar, Inc. | Devices, systems, and methods for treating a tissue of the heart |
CN117338365A (en) * | 2023-12-06 | 2024-01-05 | 东南大学泰州生物医药与医疗器械研究院 | Left auricle plugging device |
Also Published As
Publication number | Publication date |
---|---|
EP3612103B1 (en) | 2022-02-09 |
US11832829B2 (en) | 2023-12-05 |
WO2018195432A1 (en) | 2018-10-25 |
US20210077117A1 (en) | 2021-03-18 |
EP4005500A1 (en) | 2022-06-01 |
EP3612103A1 (en) | 2020-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11832829B2 (en) | Stabilization of a transseptal delivery device | |
US20230248511A1 (en) | Heart and peripheral vascular valve replacement in conjunction with a support ring | |
US10898323B2 (en) | Catheter based apical approach heart prostheses delivery system | |
US20210161661A1 (en) | Prosthetic heart valve delivery systems and methods | |
US20240050704A1 (en) | Catheter stabilization devices | |
US10154838B2 (en) | Suture and method for repairing a heart | |
KR102566728B1 (en) | Heart valve sealing device and delivery device therefor | |
US20210137681A1 (en) | Delivery Systems and Methods fro Transseptal Access to a Left Atrium | |
CN107690323B (en) | Low profile prosthetic heart valve for replacing mitral valve | |
US20070203391A1 (en) | System for Treating Mitral Valve Regurgitation | |
US20200306039A1 (en) | Transcatheter delivery systems and delivery catheters for prosthetic mitral valve delivery, and methods for prosthetic mitral valve delivery using a retrograde approach | |
US20210275300A1 (en) | Proshetic heart valve delivery system | |
US11793628B2 (en) | Transcatheter bio-prosthesis member and support structure | |
US11701229B2 (en) | Kit with coaptation aid and fixation system and methods for valve repair | |
US20240245510A1 (en) | Balloon Nosecone for Delivery Device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |